NeoRx preclinical data

NERX (Seattle) presented data from a pig model of restenosis, showing sustained patency of coronary arteries with the Biostent agent.

As reported at the Cleveland Clinic Foundation Restenosis Summit, pigs were treated with a balloon dilation of their coronary arteries, and the treated arterial wall was immediately infused with cytochalasin B. ...